Skip to content

Cullinan 制药

US · CGEM #3243 按市值排名 上市于 2021
12.93 -1.07 -7.64%
实时 - 追踪5344个代码 - 心跳于496秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例下降了1.6个百分点。

机构持股

机构持股比例
112.34% -1.63pp
机构数量
220 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund54.57%
Hedge Fund27.05%
VC/PE Fund24.38%
Public Company3.74%
Individual/Insider1.22%
Family Office/Trust0.97%
Insurance Company0.72%
Private Company0.71%
Government Pension Fund0.19%

主要股东 截至 2026-06-30

MPM BioImpact LLC 15.12% · 9.73M 股
Lynx1 Capital Management LP 13.93% · 8.96M 股
BVF Partners L.P. 8.94% · 5.75M 股
BlackRock 8.13% · 5.23M 股
T. Rowe Price Group, Inc. 5.95% · 3.83M 股
State Street Global Advisors 5.70% · 3.67M 股
Kynam Capital Management, LP 4.84% · 3.11M 股
Vanguard Capital Management, LLC 4.63% · 2.98M 股
RTW Investments, LP 3.67% · 2.36M 股
Artal Group S.A. 2.94% · 1.89M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 19次买入 · 31次卖出

姓名职务持股比例
Lynx1 Capital Management LP -- 13.93%
Jennifer Michaelson Chief Scientific Officer 0.25%
Corinne Savill Chief Business Officer 0.24%
Nadim Ahmed Chief Executive Officer 0.21%
Mary Fenton Chief Financial Officer 0.20%
Jeffrey Jones Chief Medical Officer 0.10%
Jacquelyn Sumer Chief Legal Officer, Chief Compliance Officer & Corporate Secretary 0.09%
Anthony Rosenberg Independent Chairperson 0.07%
Jeffrey Trigilio Chief Financial Officer 0.07%
Stephen Webster Independent Director --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-07 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $21.57
2026-09-07 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $4.30–21.57
2026-08-12 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -30,000 $4.30–20.26
2026-07-05 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $17.82
2026-07-05 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $4.30–17.82
2026-06-29 Mary Fenton Chief Financial Officer Other Acquisition +1,541 $8.60
2026-06-29 Jacquelyn Sumer Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Other Acquisition +2,470 $8.60
2026-06-15 Stephen Webster Independent Director Other Derivative Acquisition +25,319 $13.55
2026-06-15 Anthony Rosenberg Independent Chairperson Other Derivative Acquisition +25,319 $13.55
2026-06-15 Mary Thistle Director Other Derivative Acquisition +25,319 $13.55
2026-06-15 Andrew Allen Director Other Derivative Acquisition +21,781 $13.55
2026-06-15 David Meek Independent Director Other Derivative Acquisition +25,319 $13.55
2026-06-15 Mittie Doyle Director Other Derivative Acquisition +21,781 $13.55
2026-05-04 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $14.60–15.58
2026-05-04 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $4.30–14.60
2026-03-04 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $15.68
2026-03-04 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $4.30–15.68
2026-02-24 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -1,780 $14.14
2026-02-23 Jeffrey Jones Chief Medical Officer Open Market Disposition -4,582 $14.47
2026-02-23 Nadim Ahmed Chief Executive Officer Open Market Disposition -13,515 $14.47

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Cullinan 制药 讨论区 0 条评论

发表评论